Qube Research & Technologies LTD Eliem Therapeutics, Inc. Put Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ELYM
# of Institutions
50Shares Held
49.9MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$129 Million3.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.9MShares$16 Million0.91% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.26MShares$13.4 Million11.93% of portfolio
-
Janus Henderson Group PLC London, X03.25MShares$13.4 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA2.6MShares$10.7 Million1.03% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...